Reports on a survey of chemical industry representatives of the Environmental Protection Agency (EPA) administration of the Toxic Substances Control Act. (SL)

Reports on the Health Research Group claim that less than 7 percent of all new drugs approved by the Food and Drug Administration (FDA) in recent years were considered to be important therapeutic gains. (SL)

Recent actions by the House of Representatives concerning the funding of federal research and development agencies are detailed. While most government agencies will receive more money next year, NSF, ERDA, NASA, and the EPA will receive less money than the administration had requested. (BT)

Summarizes the recommendations made by the Panel on Chemical and Health of the President's Science Advisory Committee. Indicates the need of research in the biological effect of chemicals and a scientific flexibility rather than legal rigidity in their regulation. (CC)

Summarizes the research and development efforts involved in the 1975 annual federal budget proposals, including descriptions of priority national needs and funding of research programs. Included are statistics of actual and estimated expenses for the period from 1973 through 1975. (CC)